December 13, 2010 (Dubai, United Arab Emirates) — Four years of sublingual immunotherapy (SLIT) was found to confer benefits that were maintained for 8 years post-SLIT, and response to retreatment at ...

Daily administration of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM-SLIT) appears to be a safe and efficacious option for treating house dust mite (HDM) in younger children with ...

The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced. Taken as a once-daily tablet, the SLIT ...

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...

Please provide your email address to receive an email when new articles are posted on . The review included 11 trials and more than 6,000 patients. Improvements included symptoms, sleep, emotions, ...